Advertisement

Psychopharmacology

, Volume 60, Issue 2, pp 131–135 | Cite as

Studies on human blood platelets in affective disorder

  • Maureen Scott
  • H. W. Reading
  • J. B. Loudon
Original Investigations
Received:
Accepted:

Abstract

Platelets were examined to enable a simultaneous investigation to be made of indolylamine and electrolyte metabolism in affective disorder.

No significant differences were detected in either platelet membrane ATPase or adenyl cyclase specific activity in any of the groups of patients studied, when compared with appropriate controls. A reduced Vmax and \(\bar y\) for the 5-hydroxy-tryptamine uptake process into platelets was observed in both unipolar and bipolar depressed groups. The Km for this process was not significantly different in any of the patients from that found in control subjects.

Lithium therapy was shown not to influence significantly any of the platelet parameters examined.

It is suggested that membrane enzyme changes found in some peripheral cells in patients suffering from affective disorder, i.e. reduced Na++K+-ATPase activity in erythrocytes in depression, is not common to all peripheral cells and may or may not reflect central nervous system changes.

Key words

Affective disorder Platelets ATPase Adenyl cyclase 5-HT uptake Lithium 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ashcroft, G. W., Eccleston, D. E., Murray, L. G., Glen, A. I. M., Crawford, T. B. B., Pullar, I. A., Shields, P. J., Walter, D. S., Blackburn, I. M., Connechan, J., Lonergan, M.: Modified amine hypothesis for the aetiology of affective illness. Lancet 1972 II (1972)Google Scholar
  2. Ashcroft, G. W., Crawford, T. B. B., Cundall, R. L., Davidson, D. L., Dobson, J., Dow, R. C., Eccleston, D. E., Loose, R. W., Pullar, I. A.: 5-Hydroxytryptamine metabolism in affective illness: the effect of tryptophan administration. Psychol. Med. 3, 326–332 (1973)Google Scholar
  3. Baer, L., Platman, S. R., Fieve, R. R.: The role of electrolytes in affective disorders. Sodium, potassium and lithium ions. Arch. Gen. Psychiatry 22, 108–113 (1970)Google Scholar
  4. Barber, A. J., Jamieson, G. A.: Isolation and characterisation of plasma membranes from human blood platelets. J. Biol. Chem. 245, 6357–6365 (1970)Google Scholar
  5. Chambers, D. A., Salzmann, E. W., Neri, L. L.: Characterization of “Ecto-ATPase of human blood platelets. Arch. Biochem. Biophys. 119, 173–178 (1967)Google Scholar
  6. Coppen, A.: The biochemistry of affective disorders. Br. J. Psychiatry 113, 1237–1264 (1967)Google Scholar
  7. Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G., Munoz, R.: Diagnostic criteria for use in psychiatric research. Arch. Gen. Psychiatry 26, 57–63 (1972)Google Scholar
  8. Hallstrom, C. O. S., Rees, W. L., Pare, C. H. B., Trenchard, A., Turner, P.: Platelet uptake of 5-hydroxytryptamine and dopamine in depression. Postgrad. Med. J. 52, 40–44 (1976)Google Scholar
  9. Hesketh, J. E.: Changes in adenosine membrane triphosphatases on administration of lithium salts in vivo. Biochem. Soc. Trans. 4, 328–330 (1976)Google Scholar
  10. Hesketh, J. E., Glen, A. I. M., Reading, H. W.: Membrane ATPase activities in depressive illness. J. Neurochem. 28, 1401–1402 (1977)Google Scholar
  11. Krishna, G., Weiss, B., Brodie, B. B.: A simple, sensitive method for the assay of adenyl cyclase. J. Pharmacol. Exp. Ther. 163, 379–385 (1968)Google Scholar
  12. Lineweaver, H., Burke, H.: The determination of enzyme dissociation constants. J. Am. Chem. Soc. 56, 658–666 (1934)Google Scholar
  13. Lingjaerde, O., Jr.: Studies on the uptake of serotonin in human blood platelets in vitro. Oslo: Universitetsforlagets Trykningssentral 1971Google Scholar
  14. Lowry, O. H., Rosenbrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951)Google Scholar
  15. McCoy, E. E., Segal, D. J., Bayer, S. M., Strynadka, K. D.: Decreased ATPase and increased sodium content of platelets in Down's syndrome. New Engl. J. Med. 291, 950–953 (1974)Google Scholar
  16. Murphy, D. L., Colburn, R. W., Davis, J. M., Bunney, W. E.: Stimulation by lithium of monoamine uptake in human platelets. Life Sci. 8, 1187–1193 (1969)Google Scholar
  17. Naylor, G. J., Dick, D. A. T., Dick, E. G., Le Poidevin, D., Whyte, S. F.: Erythrocyte membrane cation carrier in depressive illness. Psychol. Med. 3, 502–508 (1973)Google Scholar
  18. Schildkraut, J. J.: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 122, 509–522 (1965)Google Scholar
  19. Sneddon, J. M.: Blood platelets as a model for monoaminecontaining neurones. Prog. Neurobiol. 1, 151–198 (1973)Google Scholar
  20. Stahl, S. M.: The human platelet. Arch. Gen. Psychiatry 34, 509–516 (1977)Google Scholar
  21. Tuomisto, J., Tukianen, E.: Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients. Nature 262, 596–598 (1976)Google Scholar
  22. Wang, Y. C., Pandey, G. N., Mendels, J., Frazer, A.: Platelet adenylate cyclase responses in depression: implications for a receptor defect. Psychopharmacologia (Berl.) 36, 291–300 (1974)Google Scholar
  23. Wing, J. K., Cooper, J. E., Sartorius, N.: The measurement and classification of psychiatric symptoms. Cambridge: Cambridge University Press 1974Google Scholar

Copyright information

© Springer-Verlag 1979

Authors and Affiliations

  • Maureen Scott
    • 1
  • H. W. Reading
    • 1
  • J. B. Loudon
    • 1
  1. 1.MRC Brain Metabolism UnitThomas Clouston ClinicEdinburghUK

Personalised recommendations

Cite article

Buy options